#+TITLE: Disorders of the Tricarboxylic Acid Cycle
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

:PROPERTIES:
#+DRAWERS: PROPERTIES
#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
#+BEAMER_THEME: Hannover
#+BEAMER_COLOR_THEME: whale
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:2 toc:nil ^:t
#+PROPERTY: header-args:R :session *R*
#+PROPERTY: header-args :cache no
#+PROPERTY: header-args :tangle yes
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: hidestars
#+STARTUP: indent
# #+BEAMER_HEADER: \subtitle{Part 1: Maple Syrup Urine Diseas}
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario | The University of Ottawa}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=white,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage{textgreek}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTeX_header: \usepackage{siunitx}
#+LaTeX_header: \usepackage{gensymb}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}
#+LaTeX_HEADER: \usepackage{tikz}
#+LaTeX_HEADER: \usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
:END:

#+BEGIN_EXPORT LaTeX
%\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}~%
%    \includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}%
%}

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}

\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=8em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{box} = [rectangle, rounded corners, text width=5em, minimum height=5em,text centered, draw=black, fill=none]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]
#+END_EXPORT 

* Introduction
** Disorders of Pyruvate Metabolism

- \alpha-Ketoglutarate Dehydrogenase Complex Deficiency
- Fumarase Deficiency
- Succinate Dehydrogenase Deficiency
- Other TCA cycle disorders

** Tricarboxylic Acid Cycle

#+CAPTION[TCA]:Tricarboxylic Acid Cycle
#+NAME: fig:tca
#+ATTR_LaTeX: :width 0.7\textwidth
[[file:./figures/tca.png]]

** Tricarboxylic Acid Cycle

#+CAPTION[TCA]:Tricarboxylic Acid Cycle Disorders
#+NAME: fig:tcad
#+ATTR_LaTeX: :width 0.7\textwidth
[[file:./figures/pyruvate_disorders.png]]

* \alpha-ketoglutarate Dehydrogenase Complex Deficiency
** \alpha-ketoglutarate Dehydrogenase Complex
- KDHC is a \alpha-ketoacid dehydrogenase analogous to PDHC and BCKD.
- Oxidation of \alpha-KGA to CoA and NADH
- E1 subunit is the thiamine dependant substrate specific dehydrogenase
  - Not regulated by phosphorylation.
- E2 subunit dihydrolipyoyl succinyl-transferase is also specific to KDHC
** Clinical Presentation
- Similar of PDHC
- developmental delay, hypotonia, opisthotonos and ataxia
  - seizures less common
- Present as neonate and early childhood

** Genetics
- AR inheritence
- E1 gene mapped to 7p13-14
- E2 gene mapped to 14q24.3
- Molecular basis of KDHC deficiencies is not resolved.

** Diagnostic Tests
- Urine organic acids
  - \uparrow \alpha-KGA, \pm other TCA intermediates
  - \alpha-KGA is a common finding, not specific for KDHC deficiency
- Blood lactate
  - Normal or increased L/P
- KDHC activity
  - cultured skin fibroblasts
  - muscle

** Treatment
- None to date

* Fumarase Deficiency

** Fumarase
- Fumarase catalyses reversible reversible hydration/dehydration of fumarate to malate
- two forms: mitochondrial and cytosolic.
  - The mitochondrial isoenzyme is involved in the TCA Cycle
  - The cytosolic isoenzyme is involved in the metabolism of amino acids and fumarate.
- Subcellular localization is established by the presence of a signal
  sequence on the amino terminus in the mitochondrial form
- SS is missing from the cytosolic isoform
- Deficiency causes impaired energy production

** Clinical Presentation
- Characterized by polyhydramnios and fetal brain abnormalities.
- In the newborn period, findings include:
  - severe neurologic abnormalities,
  - poor feeding,
  - failure to thrive
  - hypotonia.
- Fumarase deficiency is suspected in infants with multiple severe
  neurologic abnormalities in the absence of an acute metabolic
  crisis.

- Inactivity of both cytosolic and mitochondrial forms of
  fumarase are potential causes.

** Genetics

- AR inheritance
- Single gene and mRNA encode mito and cyto isoforms

** Diagnostic Tests

- Isolated, increased concentration of fumaric acid on urine organic
  acid analysis is highly suggestive of fumarase deficiency.
- Molecular
  genetic testing for fumarase deficiency is currently available

* Succinate Dehydrogenase Deficiency

**  Succinate Dehydrogenase 
- Succinate dehydrogenase is a catalytic subunit of succinate-ubiquinone oxidoreductase
  - part of complex II of the mitochondrial respiratory chain. 
- Succinate dehydrogenase contains the FAD binding site where
  succinate is deprotonated and converted to fumarate.

succinate + ubiquinone \ce{\to fumarate + ubiquinol


- Electrons removed from succinate transfer to SDHA, transfer across
  SDHB through iron sulphur clusters to the SDHC/SDHD subunits on the
  hydrophobic end of the complex anchored in the mitochondrial
  membrane.

- Mutations in this gene have been associated with a form of
  mitochondrial respiratory chain deficiency known as Leigh Syndrome.

** Complex II

https://en.wikipedia.org/wiki/SDHA#/media/File:SuccDeh.svg
